Phloretin treatment can regulate serum levels of leptin, adiponectin, triglycerides, LDL, and free fatty acids in obese mice (Liou et al. 2020), aligning with our findings and suggesting its potential in treating obesity and metabolic disorders. This evidence concerns the gene ADIPOQ and Other metabolic disease.